medline.ch Onkologie

	Randomized, multicenter phase 3 study evaluating radiotherapy versus concurrent chemoradiotherapy in nasopharyngeal carcinoma patients achieving CR/PR after induction chemotherapy. BMC Med Jin T, Jiang F, Jin QF, Hua YH, Jia YS, Du DX, Ding SB, Su HF, Lu MZ, He HJ, Chen XZ. PMID: 42436536 [PubMed - as supplied by publisher]
	Assessing collagenase-a and type-II mediated degradation of human type-I collagen by photoacoustic spectroscopy toward clinical translation in cancer progression. Sci Rep Biswas S, Chandra S, Bhat G, Mathew S, Murali TS, Mahato KK. PMID: 42436335 [PubMed - as supplied by publisher]
	Variation in Surgical Management of Stage IV Breast Cancer: Local/Institutional and Regional Geographic Considerations. Ann Surg Oncol Zaveri S, Whitham ZA, Nguyen A, Nadar A, Leitch AM, Delgado G, Farr D, Wooldridge R, Froix A, Serres SK. PMID: 42436334 [PubMed - as supplied by publisher]
	Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial. Sci Rep Nishi H, Horikoshi S, Sasada S, Kuwabara Y, Ohta K, Shigeishi H, Yoshioka Y, Konishi M, Yoshida M, Yoshimoto T, Yano K, Nakaoka M, Shigematsu H, Tanimoto K, Kakimoto N, Ohge H, Kawaguchi H. PMID: 42436291 [PubMed - as supplied by publisher]
	Deep learning for preoperative MRI-based endometrial cancer staging prediction. Sci Rep Gong C, Qi Y, Su Y, Li T, Wei Y. PMID: 42436204 [PubMed - as supplied by publisher]
	Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysis. Urol Oncol Yajima S, Yoshida S, Imasato N, Chen W, Fukushima H, Tanaka H, Masuda H, Fujii Y. PMID: 42436099 [PubMed - as supplied by publisher]
	Re: David-Dan Nguyen, Borna Tadayon Najafabadi, Lauren Lin, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Shin YS, Kim JH. PMID: 42436089 [PubMed - as supplied by publisher]
	Beyond the number of cycles: lessons from the CHRONO trial in advanced ovarian cancer. Int J Gynecol Cancer Damasceno BP, Leis LV, de Mello Graziano L, da Costa Miranda V, Lopes A. PMID: 42436083 [PubMed - as supplied by publisher]
	Surveillance of patients at risk of liver cancer: Expert opinions. J Hepatol Yip TC, Innes H, Wong GL, Jepsen P. PMID: 42436054 [PubMed - as supplied by publisher]
	"Holding Hope in Their Hands": Mothers' Meaning-Making Experiences of Handcraft-Based Art Therapy During Their Children's Cancer Treatment: An Art-based Phenomenological Qualitative Study. Semin Oncol Nurs Algül G, Ozdemir Koyu H, Kilicarslan E. PMID: 42436041 [PubMed - as supplied by publisher]
	Survival Outcomes and Prognostic Determinants in 2,983 Patients with Primary Oral Squamous Cell Carcinoma: An 11-Year Retrospective Cohort Study. J Stomatol Oral Maxillofac Surg Zhang SJ, Xiao Y, Wang GR, Cao LM, Zhang YJ, Guo SY, Tang Y, Shen KR, Zhong YH, Jia J, Bu LL, Chen G, Liu B. PMID: 42436013 [PubMed - as supplied by publisher]
	"Cumulative incidence of toxicity between 2 and 5 years following SBRT to the prostate and pelvis nodes in patients with high-risk prostate cancer ". Pract Radiat Oncol Martinez C, Cury F, Duclos M, Tsui JMG, Joseph A, Patrocinio H, Souhami L, Faria S. PMID: 42435987 [PubMed - as supplied by publisher]
	Clinical Evidence for Immune Cell-based Therapy for Head and Neck Cancer: A Systematic Review and Meta-analysis. Crit Rev Oncol Hematol Jo DH, Lee J, Kim MS. PMID: 42435951 [PubMed - as supplied by publisher]
	Cyclin-dependent kinases as signaling integrators in cancer: Structural evolution, functional plasticity, and drug discovery. Biochim Biophys Acta Mol Basis Dis Upadhyay S, Khan S, Bhardwaj M, Hassan MI. PMID: 42435947 [PubMed - as supplied by publisher]
	Should Sentinel Lymph Node Biopsy Be Performed in Patients with Early-Stage Breast Cancer? J Gynecol Obstet Hum Reprod Macías RM, Bouaziz S, Mahiou K, Bonneau C. PMID: 42435900 [PubMed - as supplied by publisher]
	Hydrogel-based platforms for localized cancer treatment: Design strategies for precision therapeutic delivery. J Control Release Salathia S, Casadidio C, Censi R. PMID: 42435859 [PubMed - as supplied by publisher]
	Beyond radiogenomics: advancing imaging integration and multi-omics horizons in cancer precision medicine. J Genet Genomics Chen Y, Li H, Chen S, Ji H, Xin J, Du M. PMID: 42435838 [PubMed - as supplied by publisher]
	Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysis. Radiother Oncol Kaufmann J, Nikolaidou E, Krabbes I, Oji N, Ferdinandus S, Hlouschek J, Wurschi G, Becker JN, Schaule J, Müller JA, Oebel L, Altmann S, Ehret F, Rühle A, Grad C. PMID: 42435818 [PubMed - as supplied by publisher]
	Dosimetric analysis of post-radiotherapy sexual dysfunction in patients receiving definitive stereotactic body radiotherapy (SBRT) for prostate cancer: a secondary analysis of MIRAGE. Radiother Oncol Massachi J, Jiang T, Neilsen BK, Wilhalme H, Ruan D, Casado M, Chong N, Zello L, Lamb JM, Ma TM, Valle LF, Cao M, Steinberg ML, Kishan AU. PMID: 42435817 [PubMed - as supplied by publisher]
	Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol Ito A, Arai Y, Kakehi Y, Yokoyama M, Sasaki K, Uemura M, Takahashi A, Nishimura K, Kawahara T, Masuda H, Yoshimura K, Kobayashi T, Eto M, Igawa T, Nishiyama N, Mochizuki T, Yokomizo A, Miyake M, Ichikawa T, Hashine K, Sato T, Sugimoto M, Nishiyama H, Kitamura H, Urologic Oncology Study Group of the Japan Clinical Oncology Group. PMID: 42435772 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1954352

Seite 1 von 97718

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung